S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
The “Perfect Storm” for Gold (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
SHOCKING Crypto Leak… (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial

Compare Stocks

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daxor Co. stock logo
DXR
Daxor
$9.75
+0.1%		$8.60
$7.11
▼
$13.13
$46.22M-0.463,430 shs8,266 shs
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daxor Co. stock logo
DXR
Daxor
+0.10%+2.09%+13.90%-2.01%+974,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Daxor Co. stock logo
DXR
Daxor
N/AN/A0.00∞N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Daxor Co. stock logo
DXR
Daxor
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Daxor Co. stock logo
DXR
Daxor
1.34%

Insider Ownership

CompanyInsider Ownership
Daxor Co. stock logo
DXR
Daxor
60.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Daxor Co. stock logo
DXR
Daxor
N/A4.74 million1.87 millionNot Optionable

DXR, EMV, IMM, and GDR Headlines

SourceHeadline
Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalDaxor Corporation Announces New Hospital Account at Leading Chicago Hospital
globenewswire.com - April 10 at 8:00 AM
Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsDaxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics
globenewswire.com - March 25 at 8:00 AM
Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
globenewswire.com - March 22 at 8:00 AM
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
globenewswire.com - March 18 at 2:18 PM
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
globenewswire.com - March 18 at 2:18 PM
Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseDaxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base
globenewswire.com - March 11 at 8:00 AM
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxors Unique Clinical Utility for Heart Failure PatientsMulti-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor's Unique Clinical Utility for Heart Failure Patients
globenewswire.com - March 8 at 8:00 AM
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceDaxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
globenewswire.com - February 26 at 8:00 AM

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Daxor logo

Daxor

NASDAQ:DXR
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.